Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases

Project Information

AVITHRAPID

Grant agreement ID: 101137192

DOI

10.3030/101137192

EC signature date 17 November 2023

Start date 1 January 2024

End date 30 June 2028

Funded under

• Health

Total cost

€ 7 459 253,75

EU contribution

€ 7 459 253,75

Coordinated by

FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (2)

Updated Data Management Plan

Updated version of the data management plan

Data Management Plan

Document that describes how AVITHRAPID data are to be handled during the project

Websites, patent fillings, videos etc. (1)

Project-Dedicated Public Website and Social Media Accounts

Dissemination tools

Documents, reports (1)

Dissemination and Exploitation Plan, including Communication Activities

Strategy for dissemination and exploitation of results as well as communication of project results and achievements

Other (1)

Ethics Deliverable

Ethics Deliverable as per the Ethics Report

Publications

Peer reviewed articles (5)

Identification, validation, and characterization of approved and investigational drugs interfering with the <scp>SARS</scp>‐<scp>CoV</scp>‐2 endoribonuclease Nsp15

Author(s): Spyros D. Chatziefthymiou, Maria Kuzikov, Sara Afandi, Greta Kovacs, Sukrit Srivastava, Andrea Zaliani, Andrey Gruzinov, Guillaume Pompidor, Michele Lunelli, Golam Rizvee Ahmed, Jörg Labahn, Johanna Hakanpää, Björn Windshügel, Michael Kolbe
Published in: Protein Science, Issue 34, 2025, ISSN 0961-8368
Publisher: Wiley
DOI: 10.1002/PRO.70156

Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New Invalidation Pipeline and Identified a True Noncovalent Inhibitor Against Papain-like Protease from SARS-CoV-2

Author(s): Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, Markus Wolf, Vittoria Monaco, Flora Cozzolino, Simona Golič Grdadolnik, Primož Šket, Janez Plavec, Daniela Iaconis, Vincenzo Summa, Angela Corona, Annalaura Paulis, Francesca Esposito, Enzo Tramontano, Maria Monti, Andrea R. Beccari, Candida Manelfi, Björn Windshügel, Philip Gribbon, Paola Storici, Andrea Zaliani
Published in: ACS Pharmacology &amp; Translational Science, Issue 8, 2025, ISSN 2575-9108
Publisher: American Chemical Society (ACS)
DOI: 10.1021/ACSPTSCI.4C00325

Genetic and structural characterization of dengue virus involved in the 2023 autochthonous outbreaks in central Italy

Author(s): Fabrizio Carletti, Gabriella De Carli, Pietro Giorgio Spezia, Cesare Ernesto Maria Gruber, Ingrid Guarnetti Prandi, Martina Rueca, Alessandro Agresta, Eliana Specchiarello, Lavinia Fabeni, Elisa San Giovanni, Chiara Arcuri, Martina Spaziante, Daniele Focosi, Paola Scognamiglio, Alessandra Barca, Emanuele Nicastri, Enrico Girardi, Giovanni Chillemi, Francesco Vairo, Fabrizio Maggi
Published in: Emerging Microbes &amp; Infections, Issue 13, 2024, ISSN 2222-1751
Publisher: Informa UK Limited
DOI: 10.1080/22221751.2024.2420734

Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity

Author(s): Ilaria Iacobucci, Irene Cipollone, Flora Cozzolino, Daniela Iaconis, Carmine Talarico, Gabriele Coppola, Stefano Morasso, Elisa Costanzi, Paolo Malune, Paola Storici, Enzo Tramontano, Francesca Esposito, Maria Monti
Published in: International Journal of Biological Macromolecules, Issue 295, 2025, ISSN 0141-8130
Publisher: Elsevier BV
DOI: 10.1016/J.IJBIOMAC.2025.139590

Comparison of colostrum and milk extracellular vesicles small RNA cargo in water buffalo

Author(s): Samanta Mecocci, Daniele Pietrucci, Marco Milanesi, Stefano Capomaccio, Luisa Pascucci, Chiara Evangelista, Loredana Basiricò, Umberto Bernabucci, Giovanni Chillemi, Katia Cappelli
Published in: Scientific Reports, Issue 14, 2024, ISSN 2045-2322
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/S41598-024-67249-6